Literature DB >> 26521299

Response to comment by P. Vassilakopoulos and colleagues.

Ulrich Jaeger1, Michael Praxmarer2, Richard Greil3.   

Abstract

Keywords:  aggressive B-cell lymphoma; first remission; randomized trial; rituximab maintenance

Mesh：

Substances：

Year:  2015        PMID： 26521299      PMCID： PMC4825306          DOI： 10.3324/haematol.2015.134288

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  2 in total

1.  Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial".

Authors:  Theodoros P Vassilakopoulos; John Apostolidis; Maria K Angelopoulou
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

2.  Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.

Authors:  Ulrich Jaeger; Marek Trneny; Helen Melzer; Michael Praxmarer; Weerasak Nawarawong; Dina Ben Yehuda; David Goldstein; Bilijana Mihaljevic; Osman Ilhan; Veronika Ballova; Michael Hedenus; Liang-Tsai Hsiao; Wing-Yan Au; Sonja Burgstaller; Gerhard Weidinger; Felix Keil; Christian Dittrich; Cathrin Skrabs; Anton Klingler; Andreas Chott; Michael A Fridrik; Richard Greil
Journal:  Haematologica       Date:  2015-04-24       Impact factor: 9.941
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.